Belite Bio, Inc (NASDAQ:BLTE)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$102.4M
- Net margin
- —
Little or no net debt.
- Total debt
- $0
- Cash
- $0
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $501.6M
- Current liabilities
- $14.9M
- Current ratio
- 33.56
Consumes cash and must keep raising it.
- Operating cash flow
- -$10K
- Free cash flow
- -$11K
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 40.2M
- Share growth (1y)
- 23.3%
- Cash runway
- 0 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BLTE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 16.69 M | 17.02 M | 13.45 M | 12.71 M | 6.55 M | 6.12 M |
| R&D Expense | 18.21 M | 15.66 M | 14.63 M | 10.31 M | 11.05 M | 9.40 M |
| Operating Expenses | 34.91 M | 32.68 M | 28.08 M | 23.02 M | 17.60 M | 15.52 M |
| Operating Income | -34.91 M | -32.68 M | -28.08 M | -23.02 M | -17.60 M | -15.52 M |
| Pretax Income | -28.36 M | -26.94 M | -25.32 M | -21.69 M | -16.32 M | -14.28 M |
| Tax Provision | 55.00 K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -28.41 M | -26.94 M | -25.32 M | -21.69 M | -16.32 M | -14.28 M |
| EPS (Basic) | -0.71 | -0.68 | -0.72 | -0.65 | -0.50 | -0.44 |
| EPS (Diluted) | -0.71 | -0.68 | -0.72 | -0.65 | -0.50 | -0.44 |
| Shares Outstanding | 40.18 M | 39.87 M | 33.54 M | 33.22 M | 32.59 M | 32.08 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.